loading

Entrada Therapeutics Inc (TRDA) 最新ニュース

pulisher
Jan 06, 2026

Entrada Therapeutics Reports Increased Losses Amid R&D Expansion - MSN

Jan 06, 2026
pulisher
Jan 03, 2026

Price-Driven Insight from (TRDA) for Rule-Based Strategy - Stock Traders Daily

Jan 03, 2026
pulisher
Dec 31, 2025

Vesuvius India Limited Moves Into Overbought Range Analysts CautiousSell Signals and Alerts & Double Or Triple Wealth - bollywoodhelpline.com

Dec 31, 2025
pulisher
Dec 30, 2025

Entrada Therapeutics Inc (TRDA) Stock News & Articles - 24/7 Wall St.

Dec 30, 2025
pulisher
Dec 26, 2025

AVP Infracon Limited Breaks Below Key Support LevelGlobal Trade Effects & Affordable Trading Strategies - Bollywood Helpline

Dec 26, 2025
pulisher
Dec 25, 2025

Analyst Downgrade: Will Entrada Therapeutics Inc stock return to pre crisis levels2025 Market Overview & Verified Entry Point Detection - moha.gov.vn

Dec 25, 2025
pulisher
Dec 25, 2025

Tubes Limited Inches Toward Key Resistance — Will It BreakRisk Adjusted Returns & Low Risk Trading Ideas - Bollywood Helpline

Dec 25, 2025
pulisher
Dec 25, 2025

Beeyu Overseas Limited Included in Top Momentum ScanVolume Profile Analysis & Big Data Market Reports - Bollywood Helpline

Dec 25, 2025
pulisher
Dec 24, 2025

Option Seller’s Risk Unlimited (in theory)REITs Market Trends & Big Gains Small Capital - bollywoodhelpline.com

Dec 24, 2025
pulisher
Dec 23, 2025

Entrada Therapeutics, Inc.Common Stock (NQ: TRDA - FinancialContent

Dec 23, 2025
pulisher
Dec 23, 2025

Analysts Are Bullish on These Healthcare Stocks: Simulations Plus (SLP), Viridian Therapeutics (VRDN) - The Globe and Mail

Dec 23, 2025
pulisher
Dec 21, 2025

Entrada Therapeutics Earnings Notes - Trefis

Dec 21, 2025
pulisher
Dec 20, 2025

Is Entrada Therapeutics Inc. stock vulnerable to regulatory risksChart Signals & Weekly Momentum Picks - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

How Entrada Therapeutics Inc. stock compares to industry benchmarksDay Trade & Safe Capital Allocation Plans - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Is Entrada Therapeutics Inc. stock positioned for long term growth2025 Volume Leaders & Fast Momentum Stock Entry Tips - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Is Entrada Therapeutics Inc. stock safe for conservative investors2025 Big Picture & Verified Trade Idea Suggestions - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

How Entrada Therapeutics Inc. stock reacts to job market dataWeekly Trade Review & Risk Controlled Swing Alerts - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

How resilient is Entrada Therapeutics Inc. stock in market downturnsJuly 2025 Snapshot & Weekly High Return Stock Forecasts - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

What insider trading reveals about Entrada Therapeutics Inc. stockQuarterly Portfolio Review & Accurate Entry/Exit Alerts - Bölüm Sonu Canavarı

Dec 19, 2025
pulisher
Dec 19, 2025

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Shares Fly 26% But Investors Aren't Buying For Growth - simplywall.st

Dec 19, 2025
pulisher
Dec 19, 2025

Will Entrada Therapeutics Inc. stock benefit from commodity pricesWeekly Trading Summary & Verified Technical Signals - DonanımHaber

Dec 19, 2025
pulisher
Dec 17, 2025

Entrada Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times

Dec 17, 2025
pulisher
Dec 15, 2025

Entrada Therapeutics : Corporate Presentation December 2025 - marketscreener.com

Dec 15, 2025
pulisher
Dec 13, 2025

5AM Venture Management LLC Has $28.95 Million Stake in Entrada Therapeutics, Inc. $TRDA - MarketBeat

Dec 13, 2025
pulisher
Dec 12, 2025

Trading Systems Reacting to (TRDA) Volatility - Stock Traders Daily

Dec 12, 2025
pulisher
Dec 08, 2025

Entrada Therapeutics Stock Jump Looks Great, But How Secure Is That Gain? - Trefis

Dec 08, 2025
pulisher
Dec 05, 2025

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Dec 05, 2025
pulisher
Nov 27, 2025

Entrada Therapeutics Reports Third Quarter 2025 Financial Results - ADVFN

Nov 27, 2025
pulisher
Nov 26, 2025

Brokerages Set Entrada Therapeutics, Inc. (NASDAQ:TRDA) Price Target at $20.67 - Defense World

Nov 26, 2025
pulisher
Nov 25, 2025

Baker Bros. Advisors LP Increases Stake in Entrada Therapeutics Inc. - GuruFocus

Nov 25, 2025
pulisher
Nov 25, 2025

Major Investment Alert: Baker Bros. Advisors Boosts Stake in Entrada Therapeutics! - TipRanks

Nov 25, 2025
pulisher
Nov 25, 2025

Kory James Wentworth Sells 8,910 Shares of Entrada Therapeutics (NASDAQ:TRDA) Stock - MarketBeat

Nov 25, 2025
pulisher
Nov 24, 2025

Insider Sell: Kory Wentworth Sells Shares of Entrada Therapeutics Inc (TRDA) - GuruFocus

Nov 24, 2025
pulisher
Nov 24, 2025

Entrada Therapeutics CFO Sells Shares Under Trading Plan - TradingView

Nov 24, 2025
pulisher
Nov 24, 2025

CFO Wentworth Sells 8,910 ($88.9K) Of Entrada Therapeutics Inc [TRDA] - TradingView

Nov 24, 2025
pulisher
Nov 24, 2025

[Form 4] Entrada Therapeutics, Inc. Insider Trading Activity - Stock Titan

Nov 24, 2025
pulisher
Nov 23, 2025

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Nov 23, 2025
pulisher
Nov 21, 2025

CFO Wentworth Files To Sell 8,910 Of Entrada Therapeutics Inc [TRDA] - TradingView

Nov 21, 2025
pulisher
Nov 20, 2025

Will Entrada Therapeutics Inc. stock deliver shareholder valueWeekly Loss Report & Daily Momentum Trading Reports - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Entrada Therapeutics (TRDA) Price Target Decreased by 10.81% to 16.83 - MSN

Nov 20, 2025
pulisher
Nov 20, 2025

Why Entrada Therapeutics Inc. stock is favored by pension fundsTrade Volume Summary & Reliable Volume Spike Trade Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

(TRDA) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com

Nov 20, 2025
pulisher
Nov 19, 2025

Questex’s Fierce Life Sciences Announces 2025 Innovation Awards Winners - GlobeNewswire Inc.

Nov 19, 2025
pulisher
Nov 19, 2025

How risky is Entrada Therapeutics Inc. stock now2025 Year in Review & Real-Time Stock Entry Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Insider Selling: Entrada Therapeutics (NASDAQ:TRDA) Director Sells 200,000 Shares of Stock - MarketBeat

Nov 19, 2025
pulisher
Nov 19, 2025

Can Entrada Therapeutics Inc. stock resist market sell offs2025 Technical Overview & Low Drawdown Trading Strategies - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Major Stock Sell-Offs at Entrada Therapeutics Inc! - TipRanks

Nov 18, 2025
pulisher
Nov 18, 2025

Applying big data sentiment scoring on Entrada Therapeutics Inc.2025 Top Decliners & Consistent Return Investment Signals - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Owner 5AM Ventures V LP Sells 200,000 ($1.8M) Of Entrada Therapeutics Inc [TRDA] - TradingView

Nov 18, 2025
pulisher
Nov 18, 2025

Chmn Parmar Sells 200,000 ($1.8M) Of Entrada Therapeutics Inc [TRDA] - TradingView

Nov 18, 2025
$102.71
price up icon 28.63%
$33.90
price up icon 2.42%
$110.57
price up icon 3.67%
$100.08
price up icon 2.03%
biotechnology ONC
$333.87
price up icon 4.22%
$176.00
price up icon 0.53%
大文字化:     |  ボリューム (24 時間):